First Tracks Biotherapeutics Shares Edge Up on Sublease Deal

Dow Jones
06/23

By Kelly Cloonan

 

Shares of First Tracks Biotherapeutics gained after the company disclosed it is subleasing office space from AnaptysBio.

The stock rose 3.7% to $19 in after-hours trading on Monday. At market close, shares were up 6.6% in the past month.

Under the agreement, AnaptysBio will sublease to First Tracks about 45,057 square feet of space in San Diego, Calif., First Tracks disclosed in a filing with the Securities and Exchange Commission.

The sublease commenced on June 15 and has a term of 12 months, with the option to extend for a renewal period that would continue until April 4, 2028, or twelve months from the commencement of the renewal term, whichever is earlier.

In April, First Tracks completed a spin-out from AnaptysBio.

 

Write to Kelly Cloonan at kelly.cloonan@wsj.com

 

(END) Dow Jones Newswires

June 22, 2026 17:27 ET (21:27 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10